STUDY ON SAFETY AND FEASIBILITY OF ELECTROCHEMOTHERAPY USED IN OPERATORY ROOM FOR A PATIENT WITH CANCER PANCREAS NOT OPERABLE

Phase 1

• Conditions: Patient suffering from exocrine or neuroendocrine, non-metastatic and inoperable pancreatic cancer, stage III; MedDRA version: 21.0Level: LLTClassification code 10033600Term: Pancreatic adenocarcinoma non-resectableSystem Organ Class: 100000004864; Therapeutic area: Diseases [C] - Hormonal diseases [C19]

• Registration Number: EUCTR2015-002077-37-IT
• Lead Sponsor: AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-09-09
• Last Update Posted: 8 October 2021

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Female and Male, Ege =18 =80 anni. Women will' perform pregnacy test before surgery and during follow up visit.
2. Consent form signed
3. Patient that could done follow up (18 months)
4. Diagnosis of pancreatic cancer, confirmed by histological test.
5. Stage III
6. Patient colud not be trated with gold-standard” (surgery)
7. Stable Disease
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 19
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 1

Exclusion Criteria

1. Age =18 =80
2. pregnant
3. Patient that not accepted to use contraceptive methods
4. Patient that coul not done surgery
5. Patient with disease not stable
6. Patient with liver , lung and /or peritoneal.
7. Patient that take phenytoin , fosphenytoin , live vaccines

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified